← All cap tiers
Cap tier

Micro Cap

Every analyzed stock in Micro Cap — 3,138 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
Sort by: A–Z Most overvalued Most shorted Buyers' strike Largest
IACQU
Irenic Acquisition Corp.
Valuation N/A
Financial Services
Price$10.02
Model IV—
P/IV—
Limited data — see page
IAE
Voya Asia Pacific High Dividend Equity Income Fund
Valuation N/A
Unknown
Price$7.13
Model IV—
P/IV—
Limited data — see page
IBAC
IB Acquisition Corp.
Valuation N/A
Industrials
Price$10.88
Model IV—
P/IV—
Limited data — see page
IBACR
IB Acquisition Corp.
Valuation N/A
Financial Services
Price$0.12
Model IV—
P/IV—
Limited data — see page
IBG
Innovation Beverage Group Ltd
Valuation N/A
Consumer Defensive
Price$0.88
Model IV—
P/IV—
Market implies +24.2%/yr vs model +2.0% · above model
IBIO
iBio, Inc.
Valuation N/A
Healthcare
Price$0.87
Model IV—
P/IV—
Market implies +49.8%/yr vs model +2.0% · above model
IBN
ICICI BANK LTD
Valuation N/A
Financial Services
Price$27.89
Model IV—
P/IV—
Limited data — see page
ICCC
IMMUCELL CORP /DE/
Deeply overvalued
Healthcare
Price$9.80
Model IV$2.86
P/IV3.59
Premium +243% Return to IV: -70.9%
Market implies +21.3%/yr vs model +9.6% · above model
ICCM
IceCure Medical Ltd.
Valuation N/A
Healthcare
Price$1.10
Model IV—
P/IV—
Market implies +78.9%/yr vs model +2.0% · above model
ICG
Intchains Group Ltd
Deeply overvalued
Technology
Price$1.11
Model IV$0.30
P/IV3.36
Premium +273% Return to IV: -73.2%
Market implies +19.1%/yr vs model +15.0% · above model
ICMB
Investcorp Credit Management BDC, Inc.
Deeply undervalued
Unknown
Price$0.70
Model IV$4.54
P/IV0.19
Discount 85% Return to IV: +548.2%
Market implies -47.7%/yr vs model +0.3% · below model
ICON
Icon Energy Corp
Deeply overvalued
Industrials
Price$0.87
Model IV$0.63
P/IV1.57
Premium +38% Return to IV: -27.6%
Market implies +3.1%/yr vs model +15.0% · below model
ICU
SeaStar Medical Holding Corp
Valuation N/A
Healthcare
Price$3.61
Model IV—
P/IV—
Market implies +16.0%/yr vs model +15.0% · in line
ICUCW
SeaStar Medical Holding Corp
Valuation N/A
Healthcare
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
IDACU
Iron Dome Acquisition I Corp.
Valuation N/A
Financial Services
Price$10.12
Model IV—
P/IV—
Limited data — see page
IDAI
T Stamp Inc
Valuation N/A
Technology
Price$3.38
Model IV—
P/IV—
Market implies +38.0%/yr vs model +2.0% · above model
IDE
Voya Infrastructure, Industrials & Materials Fund
Valuation N/A
Unknown
Price$12.28
Model IV—
P/IV—
Limited data — see page
IDN
Intellicheck, Inc.
Overvalued
Technology
Price$2.28
Model IV$1.90
P/IV1.23
Premium +20% Return to IV: -16.8%
Market implies +7.2%/yr vs model +10.9% · below model
IEAG
Infinite Eagle Acquisition Corp.
Valuation N/A
Financial Services
Price$10.14
Model IV—
P/IV—
Limited data — see page
IEAGR
Infinite Eagle Acquisition Corp.
Valuation N/A
Financial Services
Price$0.20
Model IV—
P/IV—
Limited data — see page
IEAGU
Infinite Eagle Acquisition Corp.
Valuation N/A
Financial Services
Price$10.31
Model IV—
P/IV—
Limited data — see page
IFBD
Infobird Co., Ltd
Deeply undervalued
Technology
Price$0.97
Model IV$1.89
P/IV0.48
Discount 49% Return to IV: +94.6%
Market implies -19.1%/yr vs model +2.0% · below model
IFN
ABERDEEN INDIA FUND, INC.
Valuation N/A
Unknown
Price$10.40
Model IV—
P/IV—
Limited data — see page
IFRX
InflaRx N.V.
Valuation N/A
Healthcare
Price$1.60
Model IV—
P/IV—
Market implies +143.5%/yr
IGA
Voya Global Advantage & Premium Opportunity Fund
Valuation N/A
Unknown
Price$9.97
Model IV—
P/IV—
Limited data — see page
IGAC
Invest Green Acquisition Corp
Valuation N/A
Financial Services
Price$10.10
Model IV—
P/IV—
Limited data — see page
IGACR
Invest Green Acquisition Corp
Valuation N/A
Financial Services
Price$0.15
Model IV—
P/IV—
Limited data — see page
IGC
IGC Pharma, Inc.
Valuation N/A
Healthcare
Price$0.28
Model IV—
P/IV—
Market implies +34.4%/yr
IGD
Voya GLOBAL EQUITY DIVIDEND & PREMIUM OPPORTUNITY FUND
Valuation N/A
Unknown
Price$6.31
Model IV—
P/IV—
Limited data — see page
IGI
Western Asset Investment Grade Opportunity Trust Inc.
Valuation N/A
Unknown
Price$15.33
Model IV—
P/IV—
Limited data — see page
IGR
CBRE GLOBAL REAL ESTATE INCOME FUND
Valuation N/A
Unknown
Price$11.30
Model IV—
P/IV—
Limited data — see page
IH
iHuman Inc.
Deeply undervalued
Consumer Defensive
Price$1.15
Model IV$2.41
P/IV0.49
Discount 52% Return to IV: +109.2%
Market implies -11.5%/yr vs model +2.0% · below model
IHD
Voya Emerging Markets High Dividend Equity Fund
Valuation N/A
Unknown
Price$7.48
Model IV—
P/IV—
Limited data — see page
IHT
INNSUITES HOSPITALITY TRUST
Valuation N/A
Financial Services
Price$1.11
Model IV—
P/IV—
Limited data — see page
IIF
MORGAN STANLEY INDIA INVESTMENT FUND, INC.
Valuation N/A
Unknown
Price$20.99
Model IV—
P/IV—
Limited data — see page
III
Information Services Group Inc.
Deeply overvalued
Industrials
Price$5.79
Model IV$2.47
P/IV1.83
Premium +135% Return to IV: -57.4%
Market implies +10.5%/yr vs model +0.3% · above model
IKT
Inhibikase Therapeutics, Inc.
Valuation N/A
Healthcare
Price$1.97
Model IV—
P/IV—
Market implies +95.7%/yr
ILAG
Intelligent Living Application Group Inc.
Valuation N/A
Consumer Cyclical
Price$2.61
Model IV—
P/IV—
Market implies +9.5%/yr vs model +2.0% · above model
ILLR
Triller Group Inc.
Valuation N/A
Financial Services
Price$0.08
Model IV—
P/IV—
Market implies +12.5%/yr
ILLRW
Triller Group Inc.
Deeply overvalued
Financial Services
Price$0.03
Model IV$0.02
P/IV1.98
Premium +35% Return to IV: -25.7%
Market implies +0.0%/yr vs model +17.2% · below model
ILLUW
Illumination Acquisition Corp. I
Valuation N/A
Financial Services
Price$0.37
Model IV—
P/IV—
Limited data — see page
IMA
ImageneBio, Inc.
Valuation N/A
Healthcare
Price$4.24
Model IV—
P/IV—
Market implies +50.7%/yr vs model +2.0% · above model
IMCC
IM Cannabis Corp.
Valuation N/A
Healthcare
Price$1.58
Model IV—
P/IV—
Limited data — see page
IMDX
Insight Molecular Diagnostics Inc.
Valuation N/A
Healthcare
Price$3.37
Model IV—
P/IV—
Market implies +46.5%/yr
IMKTA
INGLES MARKETS INC
Valuation N/A
Consumer Defensive
Price$85.66
Model IV—
P/IV—
Limited data — see page
IMMR
IMMERSION CORP
Valuation N/A
Technology
Price$7.43
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
IMNN
Imunon, Inc.
Valuation N/A
Healthcare
Price$1.08
Model IV—
P/IV—
Market implies +7.8%/yr vs model +15.0% · below model
IMPP
Imperial Petroleum Inc./Marshall Islands
Deeply undervalued
Industrials
Price$5.42
Model IV$23.37
P/IV0.23
Discount 77% Return to IV: +331.1%
Market implies -21.1%/yr vs model +7.0% · below model
IMRN
Immuron Ltd
Valuation N/A
Healthcare
Price$1.08
Model IV—
P/IV—
Market implies +19.9%/yr
IMSRW
Terrestrial Energy Inc. /DE/
Valuation N/A
Industrials
Price$0.96
Model IV—
P/IV—
Market implies +84.6%/yr
IMTE
Integrated Media Technology Ltd
Valuation N/A
Consumer Cyclical
Price$0.48
Model IV—
P/IV—
Market implies +53.5%/yr
IMUX
IMMUNIC, INC.
Valuation N/A
Healthcare
Price$8.19
Model IV—
P/IV—
Limited data — see page
INAB
IN8BIO, INC.
Valuation N/A
Healthcare
Price$1.34
Model IV—
P/IV—
Limited data — see page
INAC
Indigo Acquisition Corp.
Valuation N/A
Financial Services
Price$10.39
Model IV—
P/IV—
Limited data — see page
INACR
Indigo Acquisition Corp.
Valuation N/A
Financial Services
Price$0.09
Model IV—
P/IV—
Limited data — see page
INACU
Indigo Acquisition Corp.
Valuation N/A
Financial Services
Price$10.96
Model IV—
P/IV—
Limited data — see page
INBK
First Internet Bancorp
Fairly valued
Financial Services
Price$25.99
Model IV$25.81
P/IV1.01
Premium +1% Return to IV: -0.7%
INBKZ
First Internet Bancorp
Fairly valued
Financial Services
Price$25.27
Model IV$25.81
P/IV0.98
Discount 2% Return to IV: +2.2%
INBS
INTELLIGENT BIO SOLUTIONS INC.
Deeply overvalued
Healthcare
Price$1.53
Model IV$0.66
P/IV3.89
Premium +132% Return to IV: -56.9%
Market implies +4.7%/yr vs model +11.4% · below model
INDO
Indonesia Energy Corp Ltd
Valuation N/A
Energy
Price$2.74
Model IV—
P/IV—
Market implies +37.0%/yr vs model +0.0% · above model